EZH2 and lymphoma: Mice with a B cell-specific loss of EZH2 or treated with an EZH2 inhibitor completely failed to form germinal centres, whereas mice engineered to express the lymphoma-associated EZH2Y641F mutant exhibited massive germ cell hyperplasia.